<DOC>
	<DOCNO>NCT00003061</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining radiation therapy chemotherapy may kill cancer cell . PURPOSE : Phase II trial study effectiveness methotrexate cytarabine plus radiation therapy treat patient primary CNS lymphoma .</brief_summary>
	<brief_title>Combination Chemotherapy Plus Radiation Therapy Treating Patients With Primary CNS Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy methotrexate cytarabine chemotherapy combination whole-brain radiation therapy patient non-AIDS related primary central nervous system lymphoma . II . Assess response rate safety chemotherapy regimen . OUTLINE : Patients receive first course chemotherapy soon possible diagnosis staging . Methotrexate ( MTX ) IV administer 40-60 minute day 1 15 . Cytarabine ( AraC ) administer intrathecally day 1 15 . The second course chemotherapy begin day 29 bone marrow recovery . Radiation therapy begin later 3 week complete chemotherapy . Patients follow death . PROJECTED ACCRUAL : A maximum 50 patient accrue .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove nonHodgkin 's lymphoma central nervous system ( CNS ) include leptomeninges spinal cord No Burkitt 's lymphoma low grade Tcell lymphoma Must least 1 measurable lesion No AIDSrelated primary central nervous system lymphoma ( PCNSL ) No disease confine eye without localization CNS PATIENT CHARACTERISTICS : Age : 16 60 Performance status : Karnofsky 40100 % Neurological functional status 03 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : No serious impairment hepatic function Renal : No serious impairment renal function Creatinine great 1.5 mg/dL OR Creatinine clearance le 50 mL/min Cardiovascular : No serious impairment cardiac function Other : HIV negative No congenital acquire immunodeficiency syndrome No prior/concurrent systemic lymphoma No prior malignancy except : Adequately treat nonmelanoma skin cancer Carcinoma situ cervix uteri Not pregnant No severe uncontrolled infection PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent treatment immunosuppressive drug Chemotherapy : No prior chemotherapy Endocrine therapy : Corticosteroid use le 3 week allow Radiotherapy : Not specify Surgery : No prior organ transplantation</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>primary central nervous system non-Hodgkin lymphoma</keyword>
</DOC>